The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 38 | — | 20.1x | Near average | |
Growth | 16 | -58.0% | 5.6% | Below average | |
Quality | 69 | 2927.0% | 7.6% | Above average | |
Safety | 29 | 2.6x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Prothena Corporation plc is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Prothena Corporation plc shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Prothena stock shows a state of complete stability in price targets at 19 dollars over the past 7 and 30-day periods, with full consensus among the three analysts covering the stock (zero dispersion), as the high, low, and average targets are equal. This alignment indicates a unified short-term vision, despite the significant gap between the current price (9.83) and the target, reflecting expectations of a strong upside that lacks any recent updated revisions.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.